Zugriffe | |
---|---|
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 341 |
April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | September 2025 | Oktober 2025 | |
---|---|---|---|---|---|---|---|
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 6 | 2 | 1 | 4 | 6 | 11 | 0 |
Zugriffe | |
---|---|
1065.full.pdf | 197 |